We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTL.WS
276
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$37.6K ﹤0.01%
208,950
+100
+0% +$15
TLGYW
277
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$36.3K ﹤0.01%
241,944
+223,444
+1,208% +$20K
SGHC icon
278
SGHC Ltd
SGHC
$6.55B
$36.3K ﹤0.01%
+12,500
New +$44.2K
SDACW
279
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$36.2K ﹤0.01%
1,206,687
-447,409
-27% -$20.3K
AISPW
280
Airship AI Holdings Warrants
AISPW
$15.3M
$36.1K ﹤0.01%
214,361
-55,532
-21% -$5.71K
PRSTW
281
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$35.5K ﹤0.01%
253,783
+6,484
+3% +$471
XAGEW
282
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$35K ﹤0.01%
+175,000
New +$24.9K
NOTE.WS
283
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
$34.9K ﹤0.01%
78,900
-21,100
-21% -$4.97K
CLINW
284
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
$34.6K ﹤0.01%
990,054
+12,055
+1% +$721
ADTHW
285
DELISTED
AdTheorent Holding Co Warrants
ADTHW
$33.6K ﹤0.01%
295,296
+1,212
+0.4% +$111
SCRMW
286
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$33.4K ﹤0.01%
+238,300
New +$42.3K
CLRCR
287
DELISTED
ClimateRock Right
CLRCR
$33.2K ﹤0.01%
276,700
+3,014
+1% +$323
BGRYW
288
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
$33K ﹤0.01%
98,636
-110,378
-53% -$36K
AQUNR
289
DELISTED
Aquaron Acquisition Corp. Rights
AQUNR
$32.9K ﹤0.01%
182,923
-117,554
-39% -$35.3K
PAYOW
290
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$32.4K ﹤0.01%
64,780
-34,245
-35% -$22.3K
WINVR
291
DELISTED
WinVest Acquisition Corp. Right
WINVR
$32.3K ﹤0.01%
460,904
-13,397
-3% -$1.07K
PGYWW
292
Pagaya Technologies Ltd Warrants
PGYWW
$1.34M
$32.2K ﹤0.01%
123,884
+400
+0.3% +$44
LVOXW
293
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
$31.4K ﹤0.01%
142,910
-4,986
-3% -$1.37K
STIXW
294
DELISTED
Semantix, Inc. Warrant
STIXW
$31K ﹤0.01%
388,166
+6,149
+2% +$671
BRACR
295
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$30.9K ﹤0.01%
245,803
+11,591
+5% +$1.42K
SRTAW
296
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$30.4K ﹤0.01%
+48,000
New +$21.5K
VHAQ.RT
297
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$29.8K ﹤0.01%
520,275
+2,975
+0.6% +$179
AMBP.WS
298
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$29.7K ﹤0.01%
+228,555
New +$42.7K
OTECW
299
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$28.1K ﹤0.01%
+703,313
New +$32.1K
AEON.WS
300
DELISTED
AEON Biopharma Inc
AEON.WS
$27.7K ﹤0.01%
307,588
+23,400
+8% +$1.76K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.